Bone Biologics (BBLG) Gains from Investment Securities (2014 - 2025)
Bone Biologics (BBLG) reported Gains from Investment Securities of -$498.0 for Q4 2025, up 96.16% year-over-year from -$253.88 in Q4 2024, and up 58.91% quarter-over-quarter from -$1212.0 in Q3 2025.
Bone Biologics (BBLG) Gains from Investment Securities (2014 - 2025) Analysis & Trends
Bone Biologics (BBLG) has 12 years of Gains from Investment Securities data on file, last reported at -$498.0 in Q4 2025.
- Gains from Investment Securities for Q4 2025 came in at -$498.0, up 96.16% year-over-year; the trailing twelve-month figure through Dec 2025 was -$3967.0 (up 89.7% YoY), and the FY2025 annual result was $55461.0, up 5762.68% from the prior year.
- Gains from Investment Securities climbed to -$498.0 in Q4 2025 per BBLG's latest filing, from -$1212.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $509454.0 in Q1 2023 and troughed at -$2.9 million in Q4 2022.
- A 5-year average of -$177747.8 and a median of -$498.0 in 2025 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2022 and 2023: Gains from Investment Securities plunged 284935.48% in 2022, then jumped 1440.21% in 2023.
- A 5-year view of Gains from Investment Securities shows it stood at $1023.0 in 2021, then sank by 284935.48% to -$2.9 million in 2022, then soared by 99.15% to -$24763.0 in 2023, then soared by 47.67% to -$12959.0 in 2024, then soared by 96.16% to -$498.0 in 2025.
- Business Quant data shows BBLG's Gains from Investment Securities at -$498.0 in Q4 2025, -$1212.0 in Q3 2025, and -$902.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -498.00 |
| Dec 31, 2025 | -498.00 |
| Sep 30, 2025 | -1,212.00 |
| Sep 30, 2025 | -1,212.00 |
| Jun 30, 2025 | -902.00 |
| Jun 30, 2025 | -902.00 |
| Mar 31, 2025 | -1,355.00 |
| Mar 31, 2025 | -1,355.00 |
| Dec 31, 2024 | -12,959.00 |
| Dec 31, 2024 | -12,959.00 |
| Sep 30, 2024 | 9,974.00 |
| Sep 30, 2024 | 9,974.00 |
| Jun 30, 2024 | -10,785.00 |
| Jun 30, 2024 | -10,785.00 |
| Mar 31, 2024 | 74,151.00 |
| Mar 31, 2024 | 74,151.00 |
| Dec 31, 2023 | -24,763.00 |
| Dec 31, 2023 | -24,763.00 |
| Sep 30, 2023 | 274,284.00 |
| Sep 30, 2023 | 274,284.00 |